FDA Inspection
Xiamen Tiger Medical Co., Ltd.Xiamen Tiger Medical Co., Ltd. – FDA Inspection, Dec 19, 2023
Record Details
This FDA Inspection record concerns Xiamen Tiger Medical Co., Ltd., with an inspection on December 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 83c96bcf-6b21-4a8b-b191-fa494fad1a88
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1227225
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
11- 21 CFR 211.68(b)Backup data not assured as exact and complete
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.165(c)Sampling and testing plans not described
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.165(c)Sampling and testing plans not described
- 21 CFR 211.192Extent of discrepancy, failure investigations
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Xiamen Tiger Medical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xiamen Tiger Medical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.